Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity

T-E Meds, Inc., Taipei
Department of Medicine, Division of Hematology and Oncology, Far Eastern Memorial Hospital, New Taipei City
Department of Medicine, Division of Hematology and Oncology, Far Eastern Memorial Hospital, New Taipei City
Immunwork, Inc., Taipei
T-E Meds, Inc., Taipei, Taiwan; Immunwork, Inc., Taipei
T-E Meds, Inc., Taipei, Taiwan; Immunwork, Inc., Taipei
Department of Medicine, Division of Hematology and Oncology, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Taoyuan
T-E Meds, Inc., Taipei
Haematologica Early view Nov 6, 2025 https://doi.org/10.3324/haematol.2025.288692

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.288692
 
Published
2025-11-06
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
316
PDF Downloads
210

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online